A prospective, randomized, double-blind study of effectiveness and safety of esketamine as an adjunct to propofol target-controlled infusion (TCI) and determine the effect of different doses of esketamine on the median effective concentration (EC50) of propofol for gastrointestinal endoscopy in elderly patients
Latest Information Update: 17 Sep 2021
At a glance
- Drugs Esketamine (Primary) ; Propofol (Primary)
- Indications Sedation
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 17 Sep 2021 New trial record
- 08 Sep 2021 Results published in the British Journal of Clinical Pharmacology